candiduria
Conditions
Interventions
fluconazole group:NA
echinocandins group:NA
amphotericin B deoxycholate group:NA
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 years. 2. Both males and females were eligible. 3. Hospitalized patients at Huashan Hospital between January 2021 and December 2025. 4. Patients meeting the following criteria: (1) Presence of at least one clinical symptom or sign of urinary tract infection, including dysuria, urinary frequency, urinary urgency, painful urination, or lower abdominal pain; (2) Evidence of pyuria/leukocyturia confirmed by at least one of the following: a. >=5 white blood cells (WBCs) per high-power field (HPF) in centrifuged urine; b. >=10 WBCs/µL in uncentrifuged urine; c. Positive leukocyte esterase on urine dipstick testing; (3) Positive midstream clean-catch urine culture for Candida species with a colony count >=105 CFU/mL. 5. For patients with multiple hospitalizations, only data from the first hospitalization were included.
Exclusion criteria
Exclusion criteria: 1. Patients with asymptomatic candiduria; 2. Patients with concomitant Candida infections at other sites (except candidemia); 3. Patients with incomplete or missing clinical data; 4. Patients who received antifungal therapy for <48 hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical response rate; | — |
Countries
China
Contacts
Public ContactYing Li
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed